20638753|t|AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation.
20638753|a|Although the pathogenesis of sporadic Alzheimer disease (AD) is not clearly understood, it is likely dependent on several age-related factors. Diabetes is a risk factor for AD, and multiple mechanisms connecting the 2 diseases have been proposed. Hyperglycemia enhances the formation of advanced glycation end products (AGEs) that result from the auto-oxidation of glucose and fructose. The interaction of AGEs with their receptor, named RAGE, elicits the formation of reactive oxygen species that are also believed to be an early event in AD pathology. To investigate a functional link between the disorders diabetes and AD, the effect of 2 AGEs, pentosidine and glyceraldehydes-derived pyridinium (GLAP), was studied on BACE1 expression both in vivo, in streptozotocin treated rats, and in vitro in differentiated neuroblastoma cells. We showed that pentosidine and GLAP were able to upregulate BACE1 expression through their binding with RAGE and the consequent activation of NF-kappaB. In addition, both pentosidine and GLAP were found to be increased in the brain in sporadic AD patients. Our findings demonstrate that activation of the AGEs/RAGE axis, by upregulating the key enzyme for amyloid-beta production, provides a pathologic link between diabetes mellitus and AD.
20638753	0	4	AGEs	Chemical	MESH:D017127
20638753	5	9	RAGE	Gene	81722
20638753	30	35	BACE1	Gene	23621
20638753	108	125	Alzheimer disease	Disease	MESH:D000544
20638753	127	129	AD	Disease	MESH:D000544
20638753	213	221	Diabetes	Disease	MESH:D003920
20638753	243	245	AD	Disease	MESH:D000544
20638753	317	330	Hyperglycemia	Disease	MESH:D006943
20638753	357	388	advanced glycation end products	Chemical	MESH:D017127
20638753	390	394	AGEs	Chemical	MESH:D017127
20638753	435	442	glucose	Chemical	MESH:D005947
20638753	447	455	fructose	Chemical	MESH:D005632
20638753	476	480	AGEs	Chemical	MESH:D017127
20638753	508	512	RAGE	Gene	177
20638753	539	562	reactive oxygen species	Chemical	MESH:D017382
20638753	610	612	AD	Disease	MESH:D000544
20638753	679	687	diabetes	Disease	MESH:D003920
20638753	692	694	AD	Disease	MESH:D000544
20638753	712	716	AGEs	Chemical	MESH:D017127
20638753	718	729	pentosidine	Chemical	MESH:C062187
20638753	734	768	glyceraldehydes-derived pyridinium	Chemical	-
20638753	770	774	GLAP	Chemical	-
20638753	792	797	BACE1	Gene	23621
20638753	826	840	streptozotocin	Chemical	MESH:D013311
20638753	849	853	rats	Species	10116
20638753	886	899	neuroblastoma	Disease	MESH:D009447
20638753	922	933	pentosidine	Chemical	MESH:C062187
20638753	938	942	GLAP	Chemical	-
20638753	967	972	BACE1	Gene	23621
20638753	1011	1015	RAGE	Gene	177
20638753	1078	1089	pentosidine	Chemical	MESH:C062187
20638753	1094	1098	GLAP	Chemical	-
20638753	1151	1153	AD	Disease	MESH:D000544
20638753	1154	1162	patients	Species	9606
20638753	1212	1216	AGEs	Chemical	MESH:D017127
20638753	1217	1221	RAGE	Gene	81722
20638753	1263	1275	amyloid-beta	Gene	351
20638753	1323	1340	diabetes mellitus	Disease	MESH:D003920
20638753	1345	1347	AD	Disease	MESH:D000544
20638753	Positive_Correlation	MESH:D017127	MESH:D017382
20638753	Association	MESH:D003920	81722
20638753	Positive_Correlation	MESH:D017127	351
20638753	Positive_Correlation	351	81722
20638753	Positive_Correlation	MESH:C062187	23621
20638753	Positive_Correlation	MESH:D017127	23621
20638753	Association	177	23621
20638753	Positive_Correlation	MESH:D017127	MESH:D000544
20638753	Association	MESH:D017127	MESH:D003920
20638753	Positive_Correlation	23621	81722
20638753	Positive_Correlation	MESH:C062187	MESH:D000544
20638753	Bind	MESH:C062187	177
20638753	Association	MESH:D000544	177
20638753	Association	MESH:D000544	81722
20638753	Bind	MESH:D017127	177
20638753	Positive_Correlation	MESH:D017127	MESH:D006943
20638753	Association	MESH:D017127	81722
20638753	Association	MESH:D017382	MESH:D000544
20638753	Association	MESH:D017382	177

